S&P 500 Futures
(0.10%) 5 332.75 points

Dow Jones Futures
(0.04%) 40 152 points

Nasdaq Futures
(0.16%) 18 666 points

Oil
(-0.02%) $80.04

Gas
(0.72%) $2.65

Gold
(1.15%) $2 445.20

Silver
(2.91%) $32.17

Platinum
(0.29%) $1 093.20

USD/EUR
(0.00%) $0.920

USD/NOK
(-0.01%) $10.67

USD/GBP
(0.06%) $0.788

USD/RUB
(-0.25%) $90.75

Realtime updates for XORTX Therapeutics Inc. [XRTX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Upcoming Earnings Alert

Quarter results today
(bmo 2024-05-20)

Expected move: +/- 9.86%

Last Updated17 May 2024 @ 16:00

25% discount on Stockinvest.us - Use code: Podcast

2.88% $ 2.50

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection...

Stats
Today's Volume	7 382.00
Average Volume	50 742.00
Market Cap	5.00M
EPS	$0 ( 2024-05-16 )
Next earnings date	( $0 ) 2024-08-14
Last Dividend	$0.0750 ( 2014-01-31 )
Next Dividend	$0 ( N/A )
P/E	-2.29
ATR14	$0.0270 (1.08%)

XORTX Therapeutics Inc. Correlation

10 Most Positive Correlations
VTYX	0.903
CCCC	0.897
QRTEA	0.872
OCUL	0.862
ARQQ	0.861
FEMY	0.859
RGTI	0.858
NVNO	0.849
IPWR	0.849
FULC	0.847

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

XORTX Therapeutics Inc. Financials

Annual	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.520

FY	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.520

Financial Reports:

No articles found.

XORTX Therapeutics Inc. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

XORTX Therapeutics Inc. Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Information

First Dividend	$0.0500	2011-08-10
Last Dividend	$0.0750	2014-01-31
Next Dividend	$0	N/A
Payout Date	2014-02-17
Next Payout Date	N/A
# dividends	11	--
Total Paid Out	$0.795	--
Avg. Dividend % Per Year	0.00%	--
Score	1.61	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-07-05)

$0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

1.61

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXSQ	Dividend Royal	2023-12-14	Monthly	21	9.10%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
OXLC	Dividend Diamond	2023-12-14	Monthly	14	10.00%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
HRZN	Dividend Royal	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0	1.500	0	0	[0 - 0.5]
returnOnAssetsTTM	-0.551	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.647	1.500	-8.30	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	13.22	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	11.34	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	11.25	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.00232	-1.500	9.96	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-2.24	2.00	-0.745	-1.491	[0 - 30]
freeCashFlowPerShareTTM	-2.25	2.00	-1.124	-2.25	[0 - 20]
debtEquityRatioTTM	0.00563	-1.500	9.98	-10.00	[0 - 2.5]
grossProfitMarginTTM	0	1.000	-3.33	-3.33	[0.2 - 0.8]
operatingProfitMarginTTM	0	1.000	-2.00	-2.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-387.41	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				0.215

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-1.823	1.000	-0.285	0	[1 - 100]
returnOnEquityTTM	-0.647	2.50	-5.34	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-2.25	2.00	-0.749	-2.25	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-2.24	2.00	-0.745	-1.491	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.0284	1.500	-3.14	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				-2.05

XORTX Therapeutics Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

XORTX Therapeutics Inc.

XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and suppression of acute kidney injury and associated health consequences; and XRx-221, a xanthine oxidase inhibitor candidates for the treatment of diabetic nephropathy. The company has a partnership with the Icahn School of Medicine to study the incidence of acute kidney injury and hyperuricemia in patients hospitalized with COVID-19. XORTX Therapeutics Inc. is based in Vancouver, Canada.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.